EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Determinants of HbA1c Variability Across Clinical Subgroups: When the Same Value Does Not Reflect the Same Biological Risk

Mihaela Simona Popoviciu, Timea Claudia Ghitea iD, Carmen Pantis, Roxana Daniela Brata

Medicina · 2026

DOI: 10.3390/medicina62030451 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Medicina, 2026. Verfasst von Mihaela Simona Popoviciu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preclinical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 1 Decembrie, 410028 Oradea, Romania. Hauptthemen laut MEDLINE: Glycated Hemoglobin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Oradea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives: Glycated hemoglobin (HbA1c) is widely used as a marker of long-term glycemic control and metabolic risk, and represents a cornerstone in the diagnosis and management of diabetes mellitus, as endorsed by major international diabetes guidelines. However, its interpretation is typically uniform across patient populations, despite growing evidence that the biological and clinical significance of a given HbA1c value may vary depending on individual characteristics. Materials and Methods: In this cross-sectional observational study, 839 adult subjects from a real-world clinical cohort were analyzed to assess HbA1c variability and its association with cumulative diabetes-related complication burden (neuropathy, retinopathy, nephropathy, peripheral arterial disease), used here as a proxy for biological risk. Biological risk was assessed using the cumulative number of documented diabetes-related complications. To evaluate whether similar HbA1c values reflect comparable biological risk, comparisons were conducted within a predefined HbA1c stratum (6.0–6.9%). Linear regression and stratified analyses were used to explore context-dependent associations between HbA1c and cumulative complication burden.

Results

HbA1c distributions showed substantial overlap across sex and obesity categories, with no marked differences in central tendency. Within the HbA1c range of 6.0–6.9%, differences in cumulative complication burden were observed across subgroups, with males and obese individuals showing a numerically higher mean number of complications despite comparable glycemic levels. Subgroup-specific regression analyses suggested heterogeneous associations between HbA1c and complication burden, indicating potential modification of HbA1c-related risk by clinical context.

Conclusions

These findings demonstrate that the clinical interpretation of HbA1c should be contextualized. Identical HbA1c values may be associated with different complication profiles depending on sex and obesity status. Incorporating clinical context into HbA1c-based risk assessment may help inform more personalized approaches to metabolic risk stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycated HemoglobinHumansMaleCross-Sectional StudiesMiddle AgedFemaleAgedAdultDiabetes ComplicationsCohort StudiesRisk FactorsBiomarkersObesity

Stichwörter der Autor:innen

HbA1cclinical subgroupscomplication burdendiabetes mellitusmetabolic riskobesitypersonalized risk assessmentsex differences

Substanzen

Glycated HemoglobinBiomarkershemoglobin A1c protein, human

Autor:innen und Institutionen

  • Department of Preclinical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 1 Decembrie, 410028 Oradea, Romania.
  • Department of Internal Medicine II, Diabetes Mellitus, Clinical County Emergency Hospital of Oradea, 410167 Oradea, Romania.
  • Pharmacy Department, Faculty of Medicine and Pharmacy, University of Oradea, 1 University Street, 410087 Oradea, Romania.
  • Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 1 Decembrie, 410028 Oradea, Romania.

ORCID-Profile: Timea Claudia Ghitea

Förderung

  • University of Oradea

Zitieren

APA

Popoviciu, M. S., Ghitea, T. C., Pantis, C., & Brata, R. D. (2026). Determinants of HbA1c Variability Across Clinical Subgroups: When the Same Value Does Not Reflect the Same Biological Risk. Medicina. https://doi.org/10.3390/medicina62030451

Vancouver

Popoviciu MS, Ghitea TC, Pantis C, Brata RD. Determinants of HbA1c Variability Across Clinical Subgroups: When the Same Value Does Not Reflect the Same Biological Risk. Medicina. 2026. doi:10.3390/medicina62030451

BibTeX
@article{Popoviciu2026,
  author = {Popoviciu, Mihaela Simona and Ghitea, Timea Claudia and Pantis, Carmen and Brata, Roxana Daniela},
  title = {Determinants of HbA1c Variability Across Clinical Subgroups: When the Same Value Does Not Reflect the Same Biological Risk},
  journal = {Medicina},
  year = {2026},
  doi = {10.3390/medicina62030451}
}
Kostenlos starten →